Nice find. Thanks......This paragraph is worth saving and it explains why we partnered with that AI company and why we are using that company we learned about yesterday that helps design trial endpoints and then does the novel (but apparently FDA blessed) statistical evaluation afterwards.. The AI company starts with a P and the other company starts with an A. (Slow learner here. Sorry)
The paragraph:
"The company’s innovative approach to drug development is based on the concept of precision medicine, which involves tailoring treatment to the individual patient based on their genetic, environmental, and lifestyle factors. This approach is expected to increase the efficacy of treatment and reduce side effects, thereby improving the quality of life for patients."
News 
Market Data 
Discover 
